- Home
- CRK vs GRFS Comparison
CRK vs GRFS Comparison
Compare CRK & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRK
- GRFS
- Stock Information
- Founded
- CRK 1983
- GRFS 1940
- Country
- CRK United States
- GRFS Spain
- Employees
- CRK N/A
- GRFS N/A
- Industry
- CRK Oil & Gas Production
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- CRK Energy
- GRFS Health Care
- Exchange
- CRK Nasdaq
- GRFS Nasdaq
- Market Cap
- CRK 5.7B
- GRFS 5.1B
- IPO Year
- CRK N/A
- GRFS 2006
- Fundamental
- Price
- CRK $19.84
- GRFS $7.27
- Analyst Decision
- CRK Hold
- GRFS
- Analyst Count
- CRK 11
- GRFS 0
- Target Price
- CRK $14.33
- GRFS N/A
- AVG Volume (30 Days)
- CRK 2.1M
- GRFS 1.2M
- Earning Date
- CRK 04-30-2025
- GRFS 01-01-0001
- Dividend Yield
- CRK N/A
- GRFS N/A
- EPS Growth
- CRK N/A
- GRFS 283.33
- EPS
- CRK N/A
- GRFS 0.24
- Revenue
- CRK $1,254,455,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- CRK $38.07
- GRFS $8.45
- Revenue Next Year
- CRK $20.44
- GRFS $7.08
- P/E Ratio
- CRK N/A
- GRFS $35.67
- Revenue Growth
- CRK N/A
- GRFS 9.41
- 52 Week Low
- CRK $7.74
- GRFS $5.79
- 52 Week High
- CRK $22.06
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- CRK 56.58
- GRFS 37.73
- Support Level
- CRK $19.34
- GRFS $7.13
- Resistance Level
- CRK $20.73
- GRFS $7.81
- Average True Range (ATR)
- CRK 0.81
- GRFS 0.24
- MACD
- CRK 0.13
- GRFS -0.11
- Stochastic Oscillator
- CRK 71.01
- GRFS 13.33
About CRK Comstock Resources Inc.
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.